News|Articles|January 24, 2024
Process Optimization for mAb Commercial Manufacturing
Author(s)Catalent Pharma Solutions
It is essential to have access to the right tools and expertise to support process development for biologic therapies, from the clinical trial phase to commercialization.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Ask the Expert: Complying with Standards
2
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
3
How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides
4
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
5